Genetic factors did not have a direct impact on pain management but had a significant effect on the response to TKIs leading to pain alleviation. EGFR mutation subtype and the EGFR 181946 C>T SNP had a significant effect on the response to TKI inducing an indirect anti-dolorous effect.